fbpx
November 25, 2021

Triplet Regimen Boosts Survival in Metastatic Melanoma, but at a Cost Triplet Regimen Boosts Survival in Metastatic Melanoma, but at a Cost

NEW YORK (Reuters Health) – For patients with metastatic melanoma, triplet therapy with atezolizumab and vemurafenib plus cobimetinib provides significant survival benefits over vemurafenib plus cobimetinib […]
November 25, 2021

Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment

(Reuters Health) – Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance […]
November 24, 2021

What’s Hot at the World’s Premiere Breast Cancer Meeting What’s Hot at the World’s Premiere Breast Cancer Meeting

The San Antonio Breast Cancer Symposium (SABCS) 2021 will “be a great meeting,” according to Carlos Arteaga, MD, director of Simmons Comprehensive Cancer Center at UT […]
November 24, 2021

Doctor With Cancer Relies on a Close-Knit Group in Her Final Days Doctor With Cancer Relies on a Close-Knit Group in Her Final Days

The decisions have been gut-wrenching. Should she try another round of chemotherapy, even though she barely tolerated the last one? Should she continue eating, although it’s […]
November 24, 2021

Novel Sirolimus Formulation Approved for Rare Soft Tissue Sarcoma Novel Sirolimus Formulation Approved for Rare Soft Tissue Sarcoma

For the first time, a product is available specifically for use in patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors. The product […]
November 23, 2021

Most Patients With Cancer Benefit From COVID-19 Booster Most Patients With Cancer Benefit From COVID-19 Booster

People with cancer who do not develop antibodies against SARS-CoV-2 after a standard vaccination series may do so after receiving a COVID-19 booster, according to a […]
November 23, 2021

Cancer Immunologist ‘Seriously Breached’ Research Conduct Code Cancer Immunologist ‘Seriously Breached’ Research Conduct Code

A cancer immunologist who as of 2017 was “the most highly cited immunologist in Australia” has “seriously breached Codes relating to responsible research conduct,” according to […]
November 22, 2021

Certain Cancers Increase Stroke Risk, New Analysis Confirms Certain Cancers Increase Stroke Risk, New Analysis Confirms

A new systematic review revealed that people living with certain cancers as well as those in remission face a significantly higher risk for stroke than people […]
November 22, 2021

Venetoclax Shows Promise as AML Treatment Option Venetoclax Shows Promise as AML Treatment Option

Key Takeaways Venetoclax treatment combinations show benefit as first-line and follow-up therapy for adults with acute myeloid leukemia (AML), as well as patients who relapse after […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0